🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05271669
Recruiting Observational

COVID-19 Immunity and Changes Over Time

NCT05271669 · tracked via the Priya Life Science China tracker
Sponsor
Chinese University of Hong Kong
Phase
Observational
Started
2022-06-06
Last updated
2026-03-18

Condition(s) studied

COVID-19

Study summary

The risk of household spread of SARS-CoV-2 hinges on both the transmission dynamics of the virus circulating in the community as well as the seroprotection pattern of constituent members, which can be attributed to vaccination and previous infections. This study is conceptualised to assess the dynamicity of SARS-CoV-2 risk at the household level, through monitoring the pattern of seroprotection, in conjunction with the vaccination coverage, history of infection and exposure risk in the setting of Hong Kong.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * adults of age 18 or above, or children under the age of 18 with informed consent of the legal guardian * normally residing in Hong Kong * could communicate in spoken and written Chinese and/or English Exclusion Criteria: * individuals with mental illness * prisoners

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shui Shan Lee Hong Kong HONG KONG Recruiting

More Chinese University of Hong Kong trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05271669 on ClinicalTrials.gov ↗ ← All trials in China